Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Turley to Appear on CNN Special on Opioid Addiction Treatment

Neuro XPF Founder to discuss Cannabis, CBD as Alternative


News provided by

Neuro XPF

Apr 27, 2018, 01:23 ET

Share this article

Share toX

Share this article

Share toX

LAS VEGAS, April 27, 2018 /PRNewswire/ -- Former NFL All-Pro Kyle Turley will be featured in the upcoming CNN "Weed" series special on medical marijuana and CBD that begins airing Sunday, April 29. Turley will be endorsing the use of cannabis and hemp products as a way to escape the addiction of opioids in the fourth installment of CNN's series on marijuana, "Weed 4: Pot vs Pills." The show, hosted by Dr. Sanjay Gupta, will debut Sunday at 8 p.m. Eastern, 5 p.m. Pacific time.

Kyle Turley, former NFL All-Pro, and Dr. Sanjay Gupta discuss the effects of high quality CBD and medical marijuana as a safe and healthy alternative to addictive opioids at Shango Las Vegas
Kyle Turley, former NFL All-Pro, and Dr. Sanjay Gupta discuss the effects of high quality CBD and medical marijuana as a safe and healthy alternative to addictive opioids at Shango Las Vegas
Brandon Rexroad, Shango Founder/CEO, and Dr. Sanjay Gupta tour the cultivation facility inside the Shango Las Vegas location. Marijuana is a natural and effective alternative to help people with chronic pain instead of taking addictive opioids that are costing millions of people their lives.
Brandon Rexroad, Shango Founder/CEO, and Dr. Sanjay Gupta tour the cultivation facility inside the Shango Las Vegas location. Marijuana is a natural and effective alternative to help people with chronic pain instead of taking addictive opioids that are costing millions of people their lives.
Kyle Turley, former NFL All-Pro, and Dr. Sanjay Gupta discuss the effects of high quality CBD and medical marijuana as a safe and healthy alternative to addictive opioids at Shango Las Vegas Brandon Rexroad, Shango Founder/CEO, and Dr. Sanjay Gupta tour the cultivation facility inside the Shango Las Vegas location. Marijuana is a natural and effective alternative to help people with chronic pain instead of taking addictive opioids that are costing millions of people their lives.

Turley says the show takes a big step toward, "exposing the truth about this plant. People deserve the truth and I'm here to fight for it because it saved my life, the lives of my football brothers and millions of others. And unlike pharmaceuticals, THC and CBD hasn't killed a soul in the history of the world."

Earlier this week, Gupta released an open letter to U.S. Attorney General Jeff Sessions, imploring him to decriminalize marijuana. The series "Weed" has helped remove the stigmas associated with marijuana and CBD, the cannabinoid that is extracted from cannabis and hemp that research is backing up anecdotal claims with medical science.

"The reality is," Turley says, "the worldwide health care factor that marijuana has become can't be ignored any more. We are out here on our own proving that while the government seems content to feed us things that will kill us."

Turley is the founder of Neuro XPF, a line of CBD-only products made after isolating CBD and terpenes from hemp strains to create a broad spectrum, THC-free product line.

"We go the extra mile to extract all THC so any youth football player has the opportunity to use this for prevention and the college and pro athletes won't fail a drug test," Turley says.

Turley uses the isolate process to withdraw THC and then keeps the whole-plant approach. "You still have the entourage effect because you have every component of the plant except THC. We all carry THC in our system and that will ignite the entourage effect."

Turley's products are tested in Neuro XPF labs and through Shango Las Vegas and the State of Nevada. "Every batch coming through has a testing requirement and we go through state testing every three months," Turley said.

About "Weed 4: Pot vs Pills"
The description of the fourth installment says, "Politicians promise to lead the country out of the worst drug crisis in its history, but opioid abuse continues to kill Americans in record numbers.  Are our leaders ignoring a lifesaving solution? Over 115 Americans die every day from opioid overdoses, more than those killed in car accidents, from breast cancer or even guns.  Nearly 2.5 million Americans struggle with opioid addiction, and though controversial, some people believe a potentially lifesaving solution may lie in medical marijuana. In the fourth installment of his groundbreaking series, CNN chief medical correspondent Dr. Sanjay Gupta takes an in-depth look at marijuana's potential as both an alternative to opioids in treating pain and in ending opioid addiction."

About Kyle Turley
Diagnosed with chronic traumatic encephalopathy (CTE) due to the 100-plus concussions he received during the 10 years he played as an NFL offensive lineman, Kyle Turley struggled with pharmaceutical addiction, violent thoughts and suicidal tendencies — until he started taking medical marijuana. "It saved my life," he says. "I wouldn't be where I am today, I would not have my family, my kids, my house, everything I have right now, if not for cannabis." To help save other lives, Turley founded the Gridiron Cannabis Coalition to use his story and those of other players to advance the idea of marijuana as a valid medicine for neurological conditions and other athletic injuries. He donates proceeds from sales to Gridiron Greats founded by Mike Ditka. "CBD has the unique opportunity to address the growing crisis in our football community and, this is why I created Neuro XPF."

About Neuro XPF
CBD (cannabidiol) has shown in studies to have neuro-protective and antioxidative properties that could address a myriad of maladies facing our military and NFL veterans while supporting the general health and wellbeing of all athletes. Knowing the value of the plant and the hurdles that the government and big pharma has placed on marijuana, Kyle Turley has created Neuro XPF, a lab-tested, federal-guideline compliant, THC-free, CBD (hemp-derived) cannabis supplement focused on Bioavailability.

"Neuro XPF uses a special CO2 extracting process to isolate the CBD, working hard to preserve the terpenes to modulate the effect of Neuro XPF," he says. "This adds that little extra punch to Neuro XPF products so they taste better and provide more beneficial qualities." These products include various delivery systems and potencies based on preference and need. For more info, see www.neuroxpf.com or www.goshango.com.

About Shango
Shango is a premium cannabis brand licensed to a full range of award-winning cannabis products, including flower, extracts and cannabis-infused edibles, produced by select cultivators and processors in Oregon, Nevada and Washington. The Shango brand also is licensed to six full-service recreational and medical cannabis dispensaries in Oregon and Nevada. A recognized leader in the cannabis marketplace and industry, Shango sets the highest standards for product quality and consistency, and business conduct. Shango is committed to cannabis education and is a fierce advocate of the safe and responsible use of cannabis products.                       

Contact: Richard Gubbe, Shango, 815.670.2620
Virginia Martino, Brand Ltd., 702.257.2345

SOURCE Neuro XPF

Related Links

http://www.neuroxpf.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.